Literature DB >> 7746700

Treatment of tularemia with gentamicin in pediatric patients.

J T Cross1, G E Schutze, R F Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7746700

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  7 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Tularemia and once-daily gentamicin.

Authors:  Ali Hassoun; Richard Spera; John Dunkel
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 3.  Tick-borne infections in children: epidemiology, clinical manifestations, and optimal management strategies.

Authors:  Steven C Buckingham
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

4.  Bactericidal activities of antibiotics against intracellular Francisella tularensis.

Authors:  M Maurin; N F Mersali; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

5.  A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.

Authors:  Charlotte A Hall; Helen C Flick-Smith; Sarah V Harding; Helen S Atkins; Richard W Titball
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 6.  Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models.

Authors:  Yvan Caspar; Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2017-04-11       Impact factor: 5.293

7.  Serendipitous Treatment of Tularemia in Pregnancy.

Authors:  Joyce J Johnsrud; Carolyn Rebecca Smith; Robert W Bradsher
Journal:  Open Forum Infect Dis       Date:  2019-09-24       Impact factor: 3.835
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.